FarmavitaR+

1. Adaptive Clinical Trials
(Events/Events)

... statisticians and clinicians. This conference is a unique benchmarking and learning experience on an emerging area of focus for clinical trials. Key conference topics: Understand the complexitiy ...

2. Biosimilars expansion in the USA
(Biosimilars/Biosmimilars)

... the Emerging Biosimilars Landscape: Key developments in the regulatory environment priced $3,835 RBHC0216 Generic Benchmarking: Brand Erosion at Patent Expiry priced $7,600 DMHC2496  ...

3. Generic Benchmarking
(Reports/Market Report)

Generic Benchmarking: Brand Erosion at Patent Expiry Not only is Pharma facing a continued slow down in sales growth in the seven major markets, but erosion of branded drugs by generics follow patent ...

4. Biosimilars: Benchmarking the key players
(Reports/Market Report)

With increasing regulatory clarity and high revenue potential, interest in biosimilars increases With increasing regulatory clarity and the expiries of key patents covering innovator biologics, ...

5. Benchmarking Patent Expiries
(Reports/Company Report)

Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion at Patent Expiry With declining returns from drug development pipelines, preservation of branded revenues is key for manufacturers. ...

6. Benchmarking key countries
(Reports/Market Report)

Benchmarking key countries Brazil, Russia, India, China and Turkey With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market ...

7. Hospital in the Home
(Regulatory Affairs/Regulatory Affairs News)

... experience, or through the education of current staff. It is developing specific standards that will allow improvement in quality and benchmarking. HITH units should have nurse-administered, medically ...